PRENATAL COCAINE ADMINISTRATION STIMULATES FETAL BRAIN TYROSINE-HYDROXYLASE ACTIVITY

被引:44
|
作者
MEYER, JS [1 ]
DUPONT, SA [1 ]
机构
[1] UNIV MASSACHUSETTS, DEPT BIOCHEM, AMHERST, MA 01003 USA
关键词
COCAINE; TYROSINE HYDROXYLASE; CATECHOLAMINE; BRAIN; PRENATAL; FETAL; RAT;
D O I
10.1016/0006-8993(93)90783-J
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Functional effects of prenatal cocaine exposure may be mediated in part by changes in catecholaminergic development. The present study examined whether cocaine administration influenced fetal brain activity of tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine biosynthesis. Subcutaneous (s.c.) injection of pregnant rats with 40 mg/kg of cocaine HCl daily from gestational day (GD) 8 to GD20 resulted in an 8.7% stimulation of fetal whole-brain TH activity compared to controls. We then switched to a s.c. implantation procedure involving Silastic capsules filled with 80 mg of cocaine base dissolved in polyethylene glycol (PEG). Implantation of 2 such capsules on GD18 produced a 28% increase in fetal TH activity measured only 3 days later on GD21. Subsequent experiments demonstrated that GD14 implantation was equally effective in stimulating fetal TH activity on GD17, but that the enzyme was unaffected in the brains of the treated dams. When cocaine-containing capsules were implanted on GD18, removed on GD21, and the females were allowed to deliver normally, offspring TH activity was still elevated on postnatal day 10 but not later. Finally, the presence of cocaine implants from GD18 to GD21 had no influence on fetal brain neurotransmitter and metabolite concentrations, however, the treated dams exhibited significant reductions in dopamine (DA) and the serotonin metabolite, 5-hydroxyindoleacetic acid. We conclude that maternal cocaine implants rapidly but transiently stimulate TH activity in the fetal brain, and that such stimulation prevented the DA depletion observed in the dams.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [1] INCREASED TYROSINE-HYDROXYLASE IMMUNOREACTIVITY IN THE RAT CORTEX FOLLOWING PRENATAL COCAINE EXPOSURE
    AKBARI, HM
    AZMITIA, EC
    DEVELOPMENTAL BRAIN RESEARCH, 1992, 66 (02): : 277 - 281
  • [2] EFFECTS OF COCAINE ON TYROSINE-HYDROXYLASE ACTIVITY IN BRAIN-AREAS FROM SHR AND WKY
    HOSKINS, B
    OH, SK
    TSENG, YT
    ROCKHOLD, RW
    HO, IK
    BRAIN RESEARCH BULLETIN, 1990, 25 (04) : 639 - 641
  • [3] LIGHT ONSET STIMULATES TYROSINE-HYDROXYLASE ACTIVITY IN ISOLATED TELEOST RETINAS
    DEARRY, A
    VISION RESEARCH, 1991, 31 (03) : 395 - 399
  • [4] MORPHINE AND COCAINE EXERT COMMON CHRONIC ACTIONS ON TYROSINE-HYDROXYLASE IN DOPAMINERGIC BRAIN REWARD REGIONS
    BEITNERJOHNSON, D
    NESTLER, EJ
    JOURNAL OF NEUROCHEMISTRY, 1991, 57 (01) : 344 - 347
  • [5] CHRONIC COCAINE ADMINISTRATION INCREASES CNS TYROSINE-HYDROXYLASE ENZYME-ACTIVITY AND MESSENGER-RNA LEVELS AND TRYPTOPHAN-HYDROXYLASE ENZYME-ACTIVITY LEVELS
    VRANA, SL
    VRANA, KE
    KOVES, TR
    SMITH, JE
    DWORKIN, SI
    JOURNAL OF NEUROCHEMISTRY, 1993, 61 (06) : 2262 - 2268
  • [6] COCAINE BINDING-SITES IN FETAL-RAT BRAIN - IMPLICATIONS FOR PRENATAL COCAINE ACTION
    MEYER, JS
    SHEARMAN, LP
    COLLINS, LM
    MAGUIRE, RL
    PSYCHOPHARMACOLOGY, 1993, 112 (04) : 445 - 451
  • [7] USE OF MICRODIALYSIS FOR MONITORING TYROSINE-HYDROXYLASE ACTIVITY IN THE BRAIN OF CONSCIOUS RATS
    WESTERINK, BHC
    DEVRIES, JB
    DURAN, R
    JOURNAL OF NEUROCHEMISTRY, 1990, 54 (02) : 381 - 387
  • [8] ACTIVATION OF TYROSINE-HYDROXYLASE BY HALOPERIDOL IN FETAL NIGRAL TRANSPLANTS
    MELONI, R
    GALE, K
    NEUROREPORT, 1995, 6 (04) : 666 - 668
  • [9] CHRONIC IMIPRAMINE ADMINISTRATION ALTERS THE ACTIVITY AND PHOSPHORYLATION STATE OF TYROSINE-HYDROXYLASE IN DOPAMINERGIC REGIONS OF RAT-BRAIN
    ROSIN, DL
    MELIA, K
    KNORR, AM
    NESTLER, EJ
    ROTH, RH
    DUMAN, RS
    NEUROPSYCHOPHARMACOLOGY, 1995, 12 (02) : 113 - 121
  • [10] DIALKYLDITHIOCARBAMATES INHIBIT TYROSINE-HYDROXYLASE ACTIVITY IN PC12 CELLS AND IN FIBROBLASTS THAT EXPRESS TYROSINE-HYDROXYLASE
    MONTINE, TJ
    UNDERHILL, TM
    VALENTINE, WM
    GRAHAM, DG
    NEURODEGENERATION, 1995, 4 (03): : 283 - 290